TIM‐1 attenuates airway mucus hypersecretion and inflammation induced by cigarette smoke via the PI3K/Akt signaling pathway
Die Pharmazie · 01.12.2024 · 79 (10-12)
DOI: 10.31083/ph.2024.4612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Die Pharmazie, online erschienen am 01.12.2024. Verfasst von Qiang Li und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Cigarette smoke extract (CSE)-induced airway mucus hypersecretion and inflammation are prominent features of chronic obstructive pulmonary disease (COPD). As a factor associated with inflammation regulation, T cell immunoglobulin and mucin domain-1 (TIM‐1) is found to be involved in various inflammatory disorders such as asthma and COPD. In this study, the GEO database provides two human COPD gene expression datasets (GSE67472, n = 62) along with the relevant controls (n = 43) for differentially expressed gene (DEG) analyses. Candidate biomarkers are identified, and the discriminatory ability is determined using the area under the receiver operating characteristic curve (AUC) values. Furthermore, a COPD mouse model is established using CSE to validate that anti‐TIM-1 can attenuate airway mucus hypersecretion and inflammation via the PI3K/Akt signaling pathway in COPD. Anti‐TIM‐1 antibody pretreatment significantly suppresses mucin secretion, inflammatory cell infiltration, and inflammatory cytokine release in mouse lungs induced by CSE and also suppresses CSE-induced expression of MUC5AC. Western blot shows that the anti‐TIM‐1 antibody attenuates the activation of p-Akt in airway mucus hypersecretion mice induced by CSE. This study highlights the protective effect of the TIM‐1 antibody on CSE-related airway mucus hypersecretion and inflammation, in which PI3K/AKT may be involved. These findings suggest that TIM‐1 could be a potential therapeutic target for airway mucus hypersecretion.
Zitieren
APA
Li, Q., Shang, H., Li, X., Wu, G., & Qiang, L. (2024). TIM‐1 attenuates airway mucus hypersecretion and inflammation induced by cigarette smoke via the PI3K/Akt signaling pathway. Die Pharmazie, 79(10-12). https://doi.org/10.31083/ph.2024.4612
Vancouver
Li Q, Shang H, Li X, Wu G, Qiang L. TIM‐1 attenuates airway mucus hypersecretion and inflammation induced by cigarette smoke via the PI3K/Akt signaling pathway. Die Pharmazie. 2024;79(10-12). doi:10.31083/ph.2024.4612
BibTeX
@article{Li2024,
author = {Li, Qiang and Shang, Hang and Li, Xiangshun and Wu, Guangrun and Qiang, Lixia},
title = {TIM‐1 attenuates airway mucus hypersecretion and inflammation induced by cigarette smoke via the PI3K/Akt signaling pathway},
journal = {Die Pharmazie},
year = {2024},
volume = {79},
number = {10-12},
doi = {10.31083/ph.2024.4612}
}
EUVIMED